1. Introduction {#sec1}
===============

Dry eye disease (DES) is a major tear deficiency disorder which causes discomfort, visual disturbances, and tear film instability with potential damage to the ocular surface \[[@B1]\]. The tear film and ocular surface form a complex and stable system that can lose its equilibrium through multiple disturbing factors \[[@B2]\]. Despite the gain in knowledge of pathogenic factors of DES acquired in the past decades, there has been considerable discrepancy in the reported prevalence worldwide, mainly due to lack of consensus on appropriated diagnostic criteria and differences in the parameters and research methodology applied \[[@B2]\]. Two large population-based studies suggested that about 7.8% of American women and 4.7% of men aged 50 years and older had DES \[[@B3], [@B4]\]. In a study conducted in Melbourne, Australia \[[@B5]\], DES was diagnosed in subjects over 40 years old as 10.8% by rose Bengal staining, 16.3% by Schirmer\'s test, 8.6% by tear breakup time, 7.4% with two or more signs, and 5.5% with severe symptoms of DES not attributed to hay fever. Women were more likely to report severe symptoms. Risk factors for two or more signs included age and self-report of arthritis. A large study used questionnaires to investigate the prevalence of DES in Canada in all age groups \[[@B6]\]. In the 13,517 returned questionnaires (55% aged 21--50 years, 60.7% were women), 28.7% respondents reported DES. Those reporting severe DES were predominantly women, with a ratio of 46 : 1.

Some population-based studies investigating the prevalence and risk factors of DES in China have been published \[[@B7]--[@B18]\]. These studies, however, were all based on regional population. Meanwhile, the number of regions with reported data is limited. Vast regions in China have no published epidemiologic data on DES. Therefore, it is difficult to assess the overall prevalence of DES in China. Based on the current published data, the present study utilized systematic review and meta-analysis with an aim to estimate the overall pooled prevalence of DES in China. The epidemic characteristics of DES such as prevalence in different geographic regions, genders, and age groups were also explored.

2. Methods {#sec2}
==========

2.1. Search Strategy and Inclusion Criteria {#sec2.1}
-------------------------------------------

To obtain regional epidemiologic data, we searched Medline (from January 1, 1946, to October 31, 2013), Embase (from January 1, 1950, to October 31, 2013), the Cochrane Central Register of Controlled Trials (up to 2013, issue 10), Chinese Biological Medicine (January 1, 1978, to October 31, 2013), China National Knowledge Infrastructure (January 1, 1979, to October 31, 2013), Wan Fang Data (January 1, 1982, to October 31, 2013), and Chongqing VIP database (January 1, 1982, to October 31, 2013) using the free combinations of the terms "Dry Eye," "prevalence," and "China" in both English and Chinese languages. Reference lists were checked. The corresponding authors or first authors of the publications were contacted if additional information was needed, results were unclear, or relevant data were not reported.

The review and analysis were guided to be conducted by the PRISMA statement for preferred reporting of systematic reviews and meta-analysis \[[@B19]\]. Reports potentially eligible for inclusion in this systematic review and meta-analysis had to meet the following criteria: population-based studies, authentic, written either in English or in Chinese, and being able to provide sufficient information to estimate the pooled prevalence of and risk factors for DES. Population-based study needed to meet the following criteria: (i) the study populations need to be scrutinized with regard to all characteristics of the cohort before one can compare their results and (ii) the study populations need to be from special samples except hospital. If more than one study was based on the same population sample, the study with better quality was included. We excluded studies that were on the duplicate population groups but of lower quality and those that had participants drawn from a particular occupation or population and those that did not satisfy one or more inclusion criteria.

2.2. Data Extraction and Quality Assessment {#sec2.2}
-------------------------------------------

The literatures were searched independently by two researchers (Lei Liu and Yi-zhou Sun). Data were extracted from each article using a standardized form which included the first author, publication year, region or province, age range, sample size, diagnostic criteria, prevalence definition, response rage, and quality of the studies (in a score of 1--5) ([Table 1](#tab1){ref-type="table"}).

2.3. Statistical Analysis {#sec2.3}
-------------------------

Odds ratio (OR) was analyzed using RevMan version 5.0 (Review Manager, Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2010) statistical software package. Multivariate analyses to test the individual association of each variable with the overall pooled prevalence estimate using meta-regression analyses were performed by Comprehensive Meta-Analysis software version 2.0 (Biostat, Englewood Cliffs, NJ, USA). All meta-analyses were evaluated for heterogeneity using the Chi-square based *I* ^2^ test and *Q* test \[[@B20]\]. *I* ^2^ estimated the percentage of the total variance in all of the data under consideration that was related to heterogeneity. If a moderate or high level heterogeneity was observed, random-effects meta-analysis was performed by the DerSimonian and Laird method, except when using fixed-effects models. Assessment of publication bias was done by inspecting a funnel plot and using Egger\'s and Begg\'s test. *P* \< 0.05 was considered statistically significant \[[@B21], [@B22]\].

3. Results {#sec3}
==========

The flow chart showing how the identified published studies were included in the meta-analysis was demonstrated in [Figure 1](#fig1){ref-type="fig"}. We identified 119 potentially relevant articles through electronic and hand searches. After systematic review, only 12 studies \[[@B7]--[@B18]\] ([Table 1](#tab1){ref-type="table"}) met the inclusion criteria and were included in the meta-analysis.

The pooled prevalence of DES was 17.0% (95% CI: 9.9%--27.4%) (*I* ^2^ = 49.9%,  *Q* = 0.99,  *P* \< 0.001) in overall population (Figures [2(a)](#fig2){ref-type="fig"} and [2(b)](#fig2){ref-type="fig"}, [Table 2](#tab2){ref-type="table"}). The pooled prevalence rate in female individuals was significantly higher than that in males (21.6% versus 15.6%) (OR: 1.41, 95% CI: 1.31--1.52, and *P* \< 0.001) (Figures [2(c)](#fig2){ref-type="fig"} and [2(d)](#fig2){ref-type="fig"}, [Table 2](#tab2){ref-type="table"}). No significant difference was found in prevalence rate between urban China and rural China (15.3% and 21.3%, resp., OR: 1.06, 95% CI: 0.97--1.17, and *P* = 0.205) (Figures [3(c)](#fig3){ref-type="fig"} and [3(d)](#fig3){ref-type="fig"}, [Table 2](#tab2){ref-type="table"}). The prevalence rates, however, were found to be remarkably variable in different geographic regions in China. Northern China had significantly higher prevalence than Southern China (17.9% versus 16.1%) (OR: 1.97, 95% CI: 1.78--2.04, and *P* \< 0.001) (Figures [3(a)](#fig3){ref-type="fig"} and [3(b)](#fig3){ref-type="fig"}, [Table 2](#tab2){ref-type="table"}). Compared with Central China which had a prevalence rate of 10.3%, Eastern China and Western China showed significantly higher prevalence rate (12.8% and 31.3%, resp.) (OR: 2.62 and 1.38, resp., and *P* \< 0.001) ([Table 2](#tab2){ref-type="table"}). The meta-analysis data covered eight provincial/municipality/autonomous regions as shown in [Figure 4](#fig4){ref-type="fig"}.

Five studies investigated the association between age and DES. The pooled OR was 3.34 (95% CI, 2.68--4.16) (*I* ^2^ = 15%,  *P* \< 0.001) for elder age (≥60 years). Seven studies explored the relationship between the prevalence of DES and genders. The pooled OR was 1.15 (95% CI, 1.04--1.27) (*I* ^2^ = 12%,  *P* = 0.005) for female gender. In addition, diabetes also showed a significant risk factor for DES and the pooled OR was 3.82 (95% CI, 2.68--5.46) (*I* ^2^ = 10%,  *P* \< 0.001). The results are presented in [Table 3](#tab3){ref-type="table"}.

All comparisons passed the test of heterogeneity, as previously defined. Random-effects models were used for meta-analysis. There was no significant publication bias in this meta-analysis (*P* \< 0.05 for both Egger\'s test and Begg\'s test).

4. Discussion {#sec4}
=============

To our knowledge, the present study is the first meta-analysis of DES in mainland China. Our study showed a pooled prevalence rate of DES at 17%. Population-based studies evaluating the prevalence of DES differ in the definitions, diagnostic criteria for DES, selection of the study population, and the methodology applied (questionnaires and/or objective tests). Comparisons between the studies are hence difficult \[[@B2]\]. Not surprisingly, there is a discrepancy in the prevalence between our data and findings in other Asian regions and countries. The Shihpai Eye Study found that 33.7% (459/1361) of individuals aged ≥65 years in Taiwan were symptomatic, as defined by the reporting of one or more dry eye symptoms often or at all times \[[@B23]\]. In Yongin, Korea, the adjusted prevalence of dry eye disease was 33.2% in 657 subjects aged 65 years or older \[[@B24]\]. A Japanese study found that 21.6% of the female individuals aged 40 years or over were diagnosed with dry eye disease or severe symptoms, significantly higher than their male counterparts (12.5%) \[[@B25]\].

Report suggested that the prevalence of DES increased with age \[[@B26]\], which is consistent with our meta-analysis. Our findings verified that the elder population (over 60 years of age) had higher prevalence of DES than the younger population. Women are reported to be particularly susceptible to DES \[[@B27], [@B28]\]. However, some published studies based on regional population in China did not find any prevalence difference between males and females \[[@B7], [@B13]--[@B17]\]. The conflicting findings may be caused by the difference in the selection of population. The pooled prevalence in our study showed significantly higher prevalence in female subjects, consistent with majority of studies.

A larger number of DES cases were identified in individuals with diabetes, particularly those with type 2 diabetes \[[@B29]\]. Our meta-analysis illustrated significantly higher prevalence of DES in diabetes patients, which is consistent with other studies \[[@B30], [@B31]\]. The prevalence of diabetes has been increased dramatically with the rapid economic growth and the improved quality of life in China over the last thirty years \[[@B32]\]. The prevalence of DES is expected to rise further as a result. Much attention should be paid to prevent ocular surface disorder in the people with diabetes.

Other risk factors for DES (e.g., alcohol, smoking, computer use, contact lens wear, and systemic or ocular medications) were initially included in the present study but were excluded because the pooled OR was not able to be calculated as a result of insufficient information provided.

Our findings revealed remarkable difference in DES prevalence in different geographic regions in China. Western China and Northern China had significantly higher prevalence when compared with Central, Eastern, and Southern China, possibly because of the difference in the climate conditions and geographic characteristics in these regions. Previous study suggested there was a significant relationship between ultraviolet radiation and dry eye \[[@B33]\]. Qinghai-Tibetan Plateau of Western China is characterized with high altitudes, long hours of sunlight, and strong ultraviolet radiation \[[@B34]\], which may contribute to the high prevalence. Other climate conditions including low humidity and draft were believed to be related to DES \[[@B35]\], which may partially be an explanation of the higher prevalence in Northern China. Although the pooled prevalence in rural China seemed to be higher than in urban China, the difference was not statistically significant after meta-regression. Further investigation is needed.

Because the findings in pooled prevalence of DES had moderate *I* ^2^, we did meta-regression to analyze and verify the results to avoid substantial heterogeneity. Although pooled prevalence of DES in mainland China was derived in the present study, there are some limitations. Firstly, the pooled prevalence data was estimated using meta-analysis, rather than prevalence in a single national population-based study. Secondly, China is a vast country geographically with 34 provincial-level administrative units (23 provinces, 4 municipalities, 5 autonomous regions, and 2 special administrative regions). Our study only included data from 12 units, which may be inaccurate to represent the pooled prevalence of the whole country. More regional epidemiologic studies are warranted, particularly those units with no published data, so that a more accurate picture of prevalence in China can be drawn. Lastly, our data should be updated as a result of the emerging new data.

5. Conclusions {#sec5}
==============

Compared with some of the other Asian regions and countries, the pooled prevalence of DES in mainland China was lower. There is remarkable discrepancy in the prevalence in different geographic regions in China, with Western and Northern China presenting higher prevalence, possibly because of the difference in the climate conditions and geographic characteristics. Female, elder individuals, and patients with diabetes seemed to be more vulnerable to DES. More studies focusing on Chinese populations in regions without epidemiologic data are of great value.
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![Flow chart demonstrating how the identified published studies were included in the meta-analysis.](JOPH2014-748654.001){#fig1}

![(a) A forest plot displaying the pooled prevalence of dry eye syndromes (DES) in the population of mainland China. (b) A funnel plot of studies conducted on the prevalence of DES in China. (c) A forest plot displaying the pooled prevalence of DES in the male gender in China. (d) A forest plot displaying the pooled prevalence of DES in the female gender in China.](JOPH2014-748654.002){#fig2}

![(a) A forest plot displaying the pooled prevalence of DES in individuals living in Northern China. (b) A forest plot displaying the pooled prevalence of DES in individuals living in Southern China. (c) A forest plot displaying the pooled prevalence of DES in individuals living in urban China. (d) A forest plot displaying the pooled prevalence of DES in individuals living in rural China.](JOPH2014-748654.003){#fig3}

![A map displaying the prevalence rates and geographic locations in China from 12 studies included in the meta-analysis.](JOPH2014-748654.004){#fig4}

###### 

Characteristics of population-based studies on the prevalence of DES.

  Article number   First author, publication year   Province         Geographical area (latitude-longitude)   Rural/urban   Age range (year)   Sample size (*N*)   Case (*n*)   Checklist                               Diagnosis standard                  Sampling scheme   Prevalence definition   Response rate (%)   Total score
  ---------------- -------------------------------- ---------------- ---------------------------------------- ------------- ------------------ ------------------- ------------ --------------------------------------- ----------------------------------- ----------------- ----------------------- ------------------- -------------
  1                Zhuang 2012 \[[@B7]\]            Guangdong        Southern-Eastern                         Rural         14--90             2475                154          \(1\) signs, (2) BUT, (3) FL, (4) SIT   \(1\) combined with two of (2--4)   yes               yes                     88.39               5
  2                Xiao 2009 \[[@B8]\]              Guangxi          Southern-Western                         Urban         over 20            10687               1179         \(1\) signs, (2) BUT, (3) FL, (4) SIT   \(1\) combined with two of (2--4)   yes               yes                     92.04               5
  3                Sun 2010 \[[@B9]\]               Liaoning         Northern-Eastern                         Rural         20--80             1133                336          \(1\) signs, (2) BUT, (3) FL, (4) SIT   \(1\) combined with two of (2--4)   yes               no                      N/A                 3
  4                Hu 2009 \[[@B10]\]               Inner Mongolia   Northern-Central                         Rural/urban   over 40            12537               595          \(1\) signs, (2) BUT, (3) FL, (4) SIT   \(1\) combined with two of (2--4)   yes               no                      N/A                 3
  5                Tian 2009 \[[@B11]\]             Shanghai         Southern-Eastern                         Urban         60--90             746                 185          \(1\) signs, (2) BUT, (3) FL, (4) SIT   \(1\) combined with two of (2--4)   yes               yes                     93.25               5
  6                Zhang 2010 \[[@B12]\]            Shanghai         Southern-Eastern                         Urban         45--75             1601                219          \(1\) signs, (2) BUT, (3) FL, (4) SIT   \(1\) combined with two of (2--4)   yes               yes                     N/A                 4
  7                Tian 2009 \[[@B13]\]             Shanghai         Southern-Eastern                         Urban         20--95             1085                326          \(1\) signs, (2) BUT, (3) FL, (4) SIT   \(1\) combined with two of (2--4)   yes               yes                     85.7                5
  8                Chu 2011 \[[@B14]\]              Anhui            Southern-Central                         Urban         50--95             849                 178          \(1\) signs, (2) BUT, (3) FL, (5) SIT   \(1\) combined with two of (2--5)   yes               yes                     90.68               5
  9                Jie 2009 \[[@B15]\]              Beijing          Northern-Eastern                         Rural/urban   40--101            4439                411          \(1\) signs, (2) BUT, (3) FL, (5) SIT   \(1\) combined with two of (2--5)   yes               yes                     83.4                5
  10               Lu 2008 \[[@B16]\]               Qinghai          Northern-Western                         Rural         over 40            2229                965          \(1\) signs, (2) BUT, (3) FL, (5) SIT   Significant symptoms for dry eye    yes               yes                     84.69               5
  11               Guo 2010 \[[@B17]\]              Qinghai          Northern-Western                         Rural         40--91             1816                909          \(1\) signs, (2) BUT, (3) FL, (5) SIT   Significant symptoms for dry eye    yes               yes                     84.9                5
  12               Liu 2011 \[[@B18]\]              Beijing          Northern-Eastern                         Urban         20--90             1997                122          \(1\) signs, (2) BUT, (3) FL, (5) SIT   \(1\) combined with two of (2--5)   no                yes                     N/A                 3

BUT: break-up time; NA: not available; CI: confidence interval; SIT: Schirmer I test; FL: fluorescein score.

###### 

The pooled prevalence of DES in mainland China with different populations and regions.

  Variable             Number of articles   Case/total   Pooled estimate \[95% CI\] (%)   Heterogeneity *I* ^2^ (%)∗   *Q* value   OR \[95% CI\]          *P* value
  -------------------- -------------------- ------------ -------------------------------- ---------------------------- ----------- ---------------------- -----------
  General population   12                   5579/41594   17.0 \[9.9--27.4\]               49.9                         0.99                                
  Gender                                                                                                                                                   
   Male                9                    1619/12025   15.6 \[8.3--27.6\]               49.8                         0.99        1.00                    
   Female              9                    2278/12784   21.6 \[14.0--31.9\]              49.8                         0.99        1.41 \[1.31--1.52\]    \<0.001
  Rural/urban                                                                                                                                              
   Rural               5                    2485/9571    21.3 \[9.2--41.9\]               49.9                         0.99        1.00                    
   Urban               7                    2499/19425   15.3 \[10.6--21.8\]              49.7                         0.99        1.06 \[0.97--1.17\]    0.205
  Northern/Southern                                                                                                                                        
   Northern            6                    3338/24151   17.9 \[6.6--40.0\]               49.7                         0.99        1.97 \[1.78--2.04\]    \<0.001
   Southern            6                    2241/17443   16.1 \[10.2--24.3\]              49.8                         0.98        1.00                    
  Age                                                                                                                                                      
   ≤60 yrs             12                   2294/14996   14.2 \[8.7--22.3\]               49.8                         0.99        1.00                    
   \>60 yrs            12                   1856/6904    34.4 \[23.7--47.1\]              49.6                         0.98        3.49 \[3.12--3.84\]    \<0.001
  Area                                                                                                                                                     
   Eastern             7                    1753/13476   12.8 \[7.3--21.4\]               49.7                         0.98        2.62 \[2.32--2.95\]    \<0.001
   Central             2                    773/13386    10.3 \[2.2--37.1\]               49.8                         0.99        1.00                    
   Western             3                    3053/14732   31.3 \[10.1--65.0\]              49.8                         0.99        1.38 \[3.39--11.47\]   \<0.001

CI: confidence interval. ORs: odds ratios. ^\*^ *P* \< 0.001.

###### 

The pooled odds ratio for risk factors of DES.

  Variable   Pooled odds ratio   95% CI (%)   *P* value   
  ---------- ------------------- ------------ ----------- ---------
  Females    1.15                1.04         1.27        0.005
  Age        3.34                2.68         4.16        \<0.001
  Diabetes   3.82                2.68         5.46        \<0.001

CI: confidence interval.

[^1]: Academic Editor: Flavio Mantelli
